Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001446159-22-000002
Filing Date
2022-06-02
Accepted
2022-06-02 13:05:01
Documents
1
Effectiveness Date
2022-06-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 12106
  Complete submission text file 0001446159-22-000002.txt   13572
Mailing Address 2915 COMMERS DRIVE, SUITE 900 EAGAN MN 55121
Business Address 2915 COMMERS DRIVE, SUITE 900 EAGAN MN 55121 651-389-4800
Predictive Oncology Inc. (Filer) CIK: 0001446159 (see all company filings)

EIN.: 331007393 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-447847 | Film No.: 22989984
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies